$GYRE 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers THIS EMPLOYMENT AGREEMENT (this “Agreement”), dated as of October 16, 2026, by and between Gyre Therapeutics, Inc., a Delaware corporation (the “Company”), and Ying Luo (the “Executive”).
01 Sep 2026	8-K: Regulation FD Disclosure
26 Aug 2026	8-K: Regulation FD Disclosure
07 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
16 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
02 Jun 2026	8-K: Regulation FD Disclosure
14 May 2026	8-K: Regulation FD Disclosure
12 May 2026	8-K: Regulation FD Disclosure
07 May 2026	8-K: Results of Operations and Financial Condition
04 May 2026	8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +4 more
23 Mar 2026	8-K: Other Events
12 Mar 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	8-K: Regulation FD Disclosure
02 Mar 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
05 Jan 2026	8-K: Regulation FD Disclosure
07 Nov 2025	8-K: Results of Operations and Financial Condition
10 Sep 2025	8-K: Other Events
22 Aug 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
11 Aug 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

Comments